Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
JAMA. 2018 Nov 27;320(20):2099-2107. doi: 10.1001/jama.2018.14282.
JAMA. 2018.
PMID: 30357270
Free PMC article.
Clinical Trial.